Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
403.3Price to Sales
VS
Market
Sector
Industry
History
$ 2.19Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information
Ticker
CRDFCompany Name
CARDIFF ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARDIFF ONCOLOGY INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRDF - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 220.2M | 403.3 | $ 546K |
| 3/31/2025 | $ 174.96M | 297.56 | $ 588K |
| 12/31/2024 | $ 270.09M | 395.44 | $ 683K |
| 9/30/2024 | $ 209.14M | 303.54 | $ 689K |
| 6/30/2024 | $ 99.15M | 149.1 | $ 665K |
| 3/31/2024 | $ 200.37M | 328.47 | $ 610K |
| 12/31/2023 | $ 78.86M | 161.59 | $ 488K |
| 9/30/2023 | $ 50.93M | 110.72 | $ 460K |
| 6/30/2023 | $ 85.33M | 207.12 | $ 412K |
| 3/31/2023 | $ 87.12M | 220.56 | $ 395K |
Key Performance Insights, Last 5 Years
- CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) P/S stands at 1.77K.
- Over the past 5 years, CARDIFF ONCOLOGY INC's average P/S has been 428.94.
- The median P/S for CARDIFF ONCOLOGY INC during this period was 300.55
- CARDIFF ONCOLOGY INC reached its highest P/S over the past 5 years at 1.77K.
- The lowest P/S recorded by CARDIFF ONCOLOGY INC in the same timeframe 110.72
CARDIFF ONCOLOGY INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for CARDIFF ONCOLOGY INC is calculated as follows: Market Cap [ $ 600.52M ] / Revenues [ $ 339.31K ]
(=) P/S [ 1.77K ] CRDF - Price to Sales, Last 5 years
110.72
Minimum
Sep 30, 2023
1.77K
Maximum
Sep 30, 2020
428.94
Average
300.55
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |